Connor, Clark & Lunn Investment Management Ltd. - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$182,000
-43.5%
68,034
-37.4%
0.00%
-50.0%
Q1 2019$322,000
+29.8%
108,729
-30.2%
0.00%0.0%
Q4 2018$248,000
-45.1%
155,854
+27.0%
0.00%
-33.3%
Q3 2018$452,000
+55.9%
122,757
+20.0%
0.00%
+50.0%
Q2 2018$290,000
-21.2%
102,307
+3.1%
0.00%0.0%
Q1 2018$368,000
+32.4%
99,192
+2.8%
0.00%0.0%
Q4 2017$278,000
-65.7%
96,492
-46.5%
0.00%
-60.0%
Q3 2017$810,000
-48.5%
180,474
-47.3%
0.01%
-50.0%
Q2 2017$1,572,000
+20.4%
342,549
+10.4%
0.01%
+11.1%
Q1 2017$1,306,000
-12.3%
310,249
-14.0%
0.01%
-10.0%
Q4 2016$1,490,000
-67.6%
360,849
-36.4%
0.01%
-68.8%
Q3 2016$4,597,000
-30.2%
567,507
-32.8%
0.03%
-33.3%
Q2 2016$6,583,000
-21.5%
843,947
-22.3%
0.05%
-26.2%
Q1 2016$8,387,000
-38.8%
1,086,447
-14.5%
0.06%
-43.5%
Q4 2015$13,715,000
+105.9%
1,271,047
+31.8%
0.12%
+113.0%
Q3 2015$6,662,000
+48.8%
964,147
+90.8%
0.05%
+31.7%
Q2 2015$4,478,000
+8.8%
505,422
+21.1%
0.04%
+17.1%
Q1 2015$4,114,000
+29.6%
417,272
+61.0%
0.04%
+34.6%
Q4 2014$3,175,000
+329.1%
259,172
+249.8%
0.03%
+333.3%
Q3 2014$740,000
+24.8%
74,100
+0.7%
0.01%
+50.0%
Q2 2014$593,00073,6000.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2016
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders